Pharmaceutical Market Europe - October 2021 : comparemela.co

PME October 2021 - Time for pharma to ditch its cautious approach to creativity in comms, Alzheimer’s disease and beyond, Amarin is rethinking cardiovascular risk

Related Keywords

Christos Papadopoulos , Mike Crichton , Tatyana Tyx , Karim Mikhail , Simon Lovestone , Chris Ross , , Disease Area Stronghold , Rethinking Cardiovascular , European Head Commercial Excellence ,